Angiotensin receptor blocker: Clinical Trials

3 trials of Angiotensin receptor blocker, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 suspended, 1 terminated, 1 unknown. 2 Phase 4, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 42Suspended 1, Terminated 1
Not applicable1Unknown 1

Follow Angiotensin receptor blocker: new trials by email Literature Review of Angiotensin receptor blocker trials Research Report on Angiotensin receptor blocker

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Coronavirus (COVID-19) ACEi/ARB Investigation
Thiazide or Thiazide-like diuretics, Calcium Channel Blockers, ACE inhibitor - Hypertension, COVID-19
Phase 4SuspendedNational University of Ireland, Galway, Ireland24142020-04-302020-06-30
Randomized Evaluation of Beta Blocker and ACEI/ARB Treatment in MINOCA Patients - MINOCA-BAT
Beta blocker, ACEI, ARB - Myocardial Infarction With Non-obstructive Coronary Arteries
Phase 4TerminatedUppsala University1982018-12-162023-11-27
Angiotensin-II Receptor Antibodies Blockade With Losartan in Patients With Lupus Nephritis
Losartan, Enalapril - Atherosclerosis, Lupus Nephritis
Not applicableUnknownInstituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran402017-09-102018-05-16

Conditions studied

Atherosclerosis (1)  ·  COVID-19 (1)  ·  Cardiovascular Diseases (1)  ·  Coronavirus Infections (1)  ·  Hypertension (1)  ·  Lupus Nephritis (1)  ·  MINOCA (1)  ·  Myocardial Infarction (1)

Sponsors

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran (1)  ·  National University of Ireland, Galway, Ireland (1)  ·  Uppsala University (1)

Countries

Australia (1)  ·  Ireland (1)  ·  Mexico (1)  ·  New Zealand (1)  ·  Norway (1)  ·  Spain (1)  ·  Sweden (1)

Top investigators

Bertil Lindahl, Prof (1)  ·  John William McEvoy, MBBCh MHS (1)  ·  Luis E Morales-Buenrostro, PhD (1)

Results publications

PMID 33203618, PMID 42246870